8 December 2021
At the meeting of 10 November 2021 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| chronic solvent-induced neurocognitive disorder | 109/2021 | 110/2021 |
| motor neurone disease | 111/2021 | 112/2021 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| gender dysphoria | 113/2021 | 114/2021 |
Determined Amendment Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| pilonidal sinus | 115/2021 | |
The above SOPs take effect from 20 December 2021.
Summary of Changes
Finalised Declaration for:
| Condition | Declaration | Reasons for Decision |
|---|---|---|
| pilonidal sinus |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- chronic solvent encephalopathy
- motor neurone disease
- gender dysphoria
- pilonidal sinus (focussed review - prolonged sitting)
The above declaration notice appears in the Government Notices Gazette of 7 December 2021.